259 results on '"McMillan, Matthew T."'
Search Results
2. Targeting the DNA Damage Response for Radiosensitization
3. Spatially Fractionated Radiotherapy in the Era of Immunotherapy.
4. Extended Experience with a Dynamic, Data-Driven Selective Drain Management Protocol in Pancreaticoduodenectomy: Progressive Risk Stratification for Better Practice
5. Microwave Ablation for Early-Stage Non-Small Cell Lung Cancer: Don’t Put the Cart Before the Stereotactic Horse
6. Taking Theory to Practice: Quality Improvement for Pancreaticoduodenectomy and Development and Integration of the Fistula Risk Score
7. Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis
8. The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy
9. Peritoneal Drain Placement at Pancreatoduodenectomy
10. Surgical experience and the practice of pancreatoduodenectomy
11. Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer
12. Pancreatic fistula risk for pancreatoduodenectomy: an international survey of surgeon perception
13. Pancreas fistula risk prediction: implications for hospital costs and payments
14. Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (≥5 Centimeter) Non-Small Cell Lung Cancer
15. The influence of fellowship training on the practice of pancreatoduodenectomy
16. Data from DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic Cancer
17. Supplementary Figure from DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic Cancer
18. Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy
19. Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal
20. Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External Validation
21. Drain Management after Pancreatoduodenectomy: Reappraisal of a Prospective Randomized Trial Using Risk Stratification
22. Adjuvant Radiation Therapy Treatment Time Impacts Overall Survival in Gastric Cancer
23. Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies
24. Externalized Stents for Pancreatoduodenectomy Provide Value Only in High-Risk Scenarios
25. Prophylactic octreotide for pancreatoduodenectomy: more harm than good?
26. Response to: “Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation”
27. Microwave ablation using 915-MHz and 2.45-GHz systems: what are the differences?
28. Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States
29. The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy
30. Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival
31. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score‐matched analysis of a nationwide clinical oncology database
32. The Value of Drains as a Fistula Mitigation Strategy for Pancreatoduodenectomy: Something for Everyone? Results of a Randomized Prospective Multi-institutional Study
33. DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic Cancer
34. Predictive factors for pancreatic fistula following pancreatectomy
35. Does a Calculated “NAFLD Fibrosis Score” Reliably Negate the Need for Liver Biopsy in Patients Undergoing Bariatric Surgery?
36. Discordance Between Perioperative Antibiotic Prophylaxis and Wound Infection Cultures in Patients Undergoing Pancreaticoduodenectomy
37. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score–matched analysis
38. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN)
39. Association of Depressed Anti-HER2 T-Helper Type 1 Response With Recurrence in Patients With Completely Treated HER2-Positive Breast Cancer: Role for Immune Monitoring
40. Stereotactic body proton therapy for non-small cell lung cancer: Clinical indications and recommendations.
41. Safety and efficacy of stereotactic body proton therapy for high-risk lung tumors.
42. Defining the practice of pancreatoduodenectomy around the world
43. Minimally Invasive Gastrectomy for Gastric Adenocarcinoma in The United States: Utilization and Short-Term Oncologic Outcomes
44. Prophylactic octreotide in pancreatoduodenectomy: response to Yang et al.
45. Evaluating the efficacy of pre-operative fistula risk assessment
46. The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy.
47. The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy
48. Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy
49. Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy
50. Risk Factors and Mitigation Strategies for Pancreatic Fistula after Distal Pancreatectomy: Analysis of 2,026 Resections from the International, Multi-Institution Distal Pancreatectomy Study Group
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.